PURPOSE: To determine whether optical coherence tomography (OCT) device-type influences clinical grading of OCT imaging in the context of exudative age-related macular degeneration (AMD). METHODS: Ninety-six paired OCT scans from 49 patients with active exudative AMD were obtained on both the time-domain Stratus OCT system and the spectral-domain Cirrus OCT system at the same visit. Three independent graders judged each scan for the presence of intraretinal fluid (IRF) or subretinal fluid (SRF). The degree of grader consensus was evaluated and the ability of the systems to detect the presence of disease activity was analysed. RESULTS: Cirrus OCT generated a higher degree of inter-grader consensus than Stratus OCT with higher intraclass correlation coefficients for all parameters analysed. A pair-wise comparison of Cirrus OCT with Stratus OCT systems revealed that Cirrus-based gradings more frequently reported the presence of SRF and IRF and detected overall neovascular activity at a higher rate (P<0.05) compared with Stratus-based gradings. CONCLUSIONS: The choice of time-domain (Stratus) vs spectra-domain (Cirrus) OCT systems has a measurable impact on clinical decision making in exudative AMD. Spectral-domain OCT systems may be able to generate more consensus in clinical interpretation and, in particular cases, detect disease activity not detected by time-domain systems. Clinical trials using OCT-based clinical evaluations of exudative AMD may need to account for these inter-system differences in planning and analysis.
PURPOSE: To determine whether optical coherence tomography (OCT) device-type influences clinical grading of OCT imaging in the context of exudative age-related macular degeneration (AMD). METHODS: Ninety-six paired OCT scans from 49 patients with active exudative AMD were obtained on both the time-domain Stratus OCT system and the spectral-domain Cirrus OCT system at the same visit. Three independent graders judged each scan for the presence of intraretinal fluid (IRF) or subretinal fluid (SRF). The degree of grader consensus was evaluated and the ability of the systems to detect the presence of disease activity was analysed. RESULTS: Cirrus OCT generated a higher degree of inter-grader consensus than Stratus OCT with higher intraclass correlation coefficients for all parameters analysed. A pair-wise comparison of Cirrus OCT with Stratus OCT systems revealed that Cirrus-based gradings more frequently reported the presence of SRF and IRF and detected overall neovascular activity at a higher rate (P<0.05) compared with Stratus-based gradings. CONCLUSIONS: The choice of time-domain (Stratus) vs spectra-domain (Cirrus) OCT systems has a measurable impact on clinical decision making in exudative AMD. Spectral-domain OCT systems may be able to generate more consensus in clinical interpretation and, in particular cases, detect disease activity not detected by time-domain systems. Clinical trials using OCT-based clinical evaluations of exudative AMD may need to account for these inter-system differences in planning and analysis.
Authors: M R Hee; C R Baumal; C A Puliafito; J S Duker; E Reichel; J R Wilkins; J G Coker; J S Schuman; E A Swanson; J G Fujimoto Journal: Ophthalmology Date: 1996-08 Impact factor: 12.079
Authors: Andrew A Moshfeghi; Philip J Rosenfeld; Carmen A Puliafito; Stephan Michels; Erin N Marcus; Joshua D Lenchus; Anna S Venkatraman Journal: Ophthalmology Date: 2006-10-05 Impact factor: 12.079
Authors: Anne E Fung; Geeta A Lalwani; Philip J Rosenfeld; Sander R Dubovy; Stephan Michels; William J Feuer; Carmen A Puliafito; Janet L Davis; Harry W Flynn; Maria Esquiabro Journal: Am J Ophthalmol Date: 2007-04 Impact factor: 5.258
Authors: Pearse A Keane; Sandra Liakopoulos; Renu V Jivrajka; Karen T Chang; Tarek Alasil; Alexander C Walsh; Srinivas R Sadda Journal: Invest Ophthalmol Vis Sci Date: 2009-03-05 Impact factor: 4.799
Authors: Nanfei Zhang; Greg C Hoffmeyer; Ellen S Young; Russell E Burns; Katrina P Winter; Sandra S Stinnett; Cynthia A Toth; Glenn J Jaffe Journal: Am J Ophthalmol Date: 2007-05-23 Impact factor: 5.258
Authors: Gwénolé Quellec; Kyungmoo Lee; Martin Dolejsi; Mona K Garvin; Michael D Abràmoff; Milan Sonka Journal: IEEE Trans Med Imaging Date: 2010-04-01 Impact factor: 10.048
Authors: Xinjian Chen; Meindert Niemeijer; Li Zhang; Kyungmoo Lee; Michael D Abramoff; Milan Sonka Journal: IEEE Trans Med Imaging Date: 2012-03-19 Impact factor: 10.048
Authors: Melissa M Liu; Yulia Wolfson; Susan B Bressler; Diana V Do; Howard S Ying; Neil M Bressler Journal: Invest Ophthalmol Vis Sci Date: 2014-03-06 Impact factor: 4.799